Radiofrequency volumetric tissue reduction of turbinate hypertrophy (IPG36)
The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on radiofrequency volumetric tissue reduction of turbinate hypertrophy in January 2004. In accordance with the Interventional Procedures Programme Process Guide, guidance on procedures with special arrangements are reviewed 3 years after publication and the procedure is reassessed if important new evidence is available.
The guidance was considered for reassessment in October 2009 and it was concluded that NICE will not be updating this guidance at this stage. However, if you believe there is new evidence which should warrant a review of our guidance, please contact us via the email address below.
In the inside of each nostril there are bony projections called turbinates. Turbinates increase the surface area of the inside of the nose, improving its air-filtering functions. There are three turbinates (inferior, middle, and superior) on each side of the nose. Swelling of the inferior turbinates (turbinate hypertrophy) can lead to blockage of nasal breathing (turbinate dysfunction).
Radiofrequency volumetric tissue reduction for turbinate hypertrophy is an outpatient procedure in which a submuscosal scar is created by the use of a needle electrode inserted into soft tissue.
The procedure involves the injection of a local anaesthetic. A needle electrode is then placed into the anterior inferior turbinate where the radiofrequency energy is delivered by a power generator. There is a variation in the energy levels and temperatures used.
E04.2 Excision of turbinate of nose NEC
Includes: Reduction of turbinate of nose NEC
Y11.4 Radiofrequency controlled thermal destruction of organ NOC
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy: guidance (web format)
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy - guidance
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy - information for people considering the procedure, and for the public
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy, distribution list
- Interventional procedures consultation document - radiofrequency volumetric tissue reduction for turbinate hypertrophy
- Overview of radiofrequency volumetric tissue reduction for turbinate hypertrophy
- Consent - procedures for which the benefits and risks are uncertain
This page was last updated: 15 June 2012
Information for the public
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.